ASL PESCARA-Presidio Ospedaliero Pescara
- Address
- Via Fonte Romana 8, 65124 Pescara, Italy
ASL PESCARA-Presidio Ospedaliero Pescara - Oncology and Hematology Research Center
ASL PESCARA-Presidio Ospedaliero Pescara is a comprehensive medical research center with significant expertise in oncology and hematologic malignancies. The center participates in advanced clinical trials spanning both solid tumors and blood cancers, demonstrating a commitment to developing innovative therapeutic approaches for patients with complex and high-risk malignancies.
- Primary Central Nervous System Lymphoma (PCNSL) with advanced chemotherapy protocols and autologous stem cell transplantation
- Non-Small Cell Lung Cancer (NSCLC) with targeted therapies for EGFR mutations
- Pediatric oncology specializing in high-risk neuroblastoma treatment strategies
- Hematologic disorders including myelodysplastic syndromes (MDS) and multiple myeloma
The center's research portfolio reflects expertise in both personalized medicine approaches using molecular biomarkers and intensive multimodal treatment regimens. Their participation in international collaborative trials demonstrates commitment to advancing care for rare conditions such as primary CNS lymphoma and pediatric neuroblastoma, while also contributing to the development of novel immunotherapies and targeted agents for conditions like EGFR-mutant lung cancer and multiple myeloma requiring transplant-ineligible treatment options.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 24 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Associazione Qol-One1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in ASL PESCARA-Presidio Ospedaliero Pescara
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of Osimertinib in Treatment-Naïve Patients with EGFR Mutant NSCLC Stratified by TP53 Mutational Status | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Phase III | Not Recruiting | May 2022 | — |
IMP list
lock Showing 1 of 24 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Busulfan | 2 | Unknown | 2021-06-21 | 2024-11-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.